I assumed “improved brain insulin responsiveness” meant the brain was answering insulin more strongly. Then I read the numbers behind this week’s peanut headline and found the opposite. After 16 weeks of daily peanuts, one small patch of older adults’ brain tissue reacted to insulin less, and that weaker reaction is what the industry press release calls a benefit. Which raises a nerdy question first: how do you watch insulin work inside a living person’s head? Nobody biopsies a 67-year-old’s hippocampus to check.

The headline reached ScienceDaily as “a surprising brain benefit of eating peanuts every day,” and the text under it is a press release from The Peanut Institute. The research comes from the NUTRIM institute at Maastricht University Medical Center, published in Food & Function by a team led by Peter Joris. Thirty-one healthy adults aged 60 to 75 ate 60 grams of unsalted, skin-roasted peanuts a day, about two servings, for 16 weeks. They also spent 16 weeks eating no peanuts at all, with an eight-week washout in between, so each person served as their own control. This is the second paper from the trial. The first, in Clinical Nutrition last year, reported more blood reaching the brain and better verbal recall. This one was meant to show the insulin side, and Joris says it did: peanuts “beneficially affected insulin responsiveness” in memory-related brain regions. “As people age, the brain may become less responsive to insulin, which has been linked to age-related cognitive decline,” he said.

The method won me over before the results did. The researchers spray insulin up the nose, 160 units according to the trial registration, and it slips into the brain along nasal pathways without flooding the bloodstream. Before and after the spray, an MRI technique called arterial spin labeling magnetically tags the water in your arterial blood and tracks where it pours into brain tissue. The shift in local blood flow becomes the readout, a map of where the brain reacted when the hormone arrived. That map shows blood flow, which stands in for insulin signaling. It can’t tell you directly what your neurons are doing with the hormone.

Across the whole brain, the team found one region where peanuts made a difference: a cluster of 552 cubic millimeters in the right hemisphere, a little over half a cubic centimeter of tissue, according to the paper’s abstract. After the peanut phase, blood flow there rose less in response to insulin than after the no-peanut phase. The average difference was 5.4 milliliters per 100 grams of tissue per minute, with P = 0.044. That clears the conventional 0.05 bar, though the reported spread around the average (plus or minus 5.4) is as wide as the average itself, and the summary doesn’t say whether that figure is a standard deviation or a standard error.

The location is fuzzier than the release lets on. The team placed the cluster using the Harvard-Oxford brain atlas, which gives every spot of tissue a probability of belonging to each named structure. Averaged across the cluster, the best match was the lingual gyrus, a visual-processing region, at 20 percent. The hippocampus, the memory structure the coverage leads with, came in at 14 percent. The posterior cingulate gyrus, which the release lists among the memory regions that benefited, scored 1 percent.

Wait, so a weaker response counts as the improvement? The Maastricht group has argued this before. In a 2024 American Journal of Clinical Nutrition trial with the same 60-gram, 16-week crossover design in older adults with overweight or obesity, mixed nuts shrank the insulin-triggered blood-flow response in five occipital and frontal clusters, and the authors read that as improved brain insulin action. A small 2017 trial in Aging found that intranasal insulin raised perfusion in older adults’ occipital gray matter and thalamus compared with placebo, and that team called the rise improved perfusion. The two studies ask different questions (insulin versus placebo in one, peanuts versus no peanuts in the other), so neither disproves the other. Together they show that “smaller is healthier” is how the Maastricht group interprets the scan. The new trial doesn’t test that interpretation, and the paper links that half-centimeter of tissue to no measure of how well anyone remembered anything. Before I’d call a smaller blood-flow blip a benefit, I’d want to see it move alongside something a person can feel.

Below the neck, where insulin does most of its daily work, nothing changed. The team scanned participants’ abdomens for liver fat and checked fasting markers of glucose metabolism, blood fats and inflammation, and all of them remained unchanged between phases. The mixed-nut trial, by contrast, lowered liver fat, LDL cholesterol and systolic blood pressure. In this trial, about 340 calories’ worth of peanuts a day, by PsyPost’s account, left the liver and the fasting blood chemistry where they started.

Peanuts have better evidence than this headline gives them, and it comes from the same 31 people. In the Clinical Nutrition paper, overall brain blood flow rose 3.6 percent during the peanut phase, gray matter flow 4.5 percent, frontal lobe flow 6.6 percent and temporal lobe flow 4.9 percent, according to PsyPost’s write-up. Delayed verbal recall improved 5.8 percent, and systolic blood pressure fell about 5 mmHg with pulse pressure down about 4, while executive function and psychomotor speed showed no significant change. Joris points to L-arginine, which the lining of your blood vessels turns into nitric oxide, the gas that tells artery walls to relax and widen. The researchers also name the papery skins’ polyphenols and the fat profile, and they admit the mechanism is unclear. Those numbers are extra outcomes from one experiment, not independent confirmation, and every participant knew whether they were eating peanuts.

WHAT THE SAME TRIAL ALSO MEASURED
3.6 percent
rise in overall brain blood flow
5.8 percent
better delayed verbal recall
5 mmHg
drop in systolic blood pressure
Companion results from the same 31 participants, who knew when they were eating peanuts. Source: PsyPost: design, outcomes and limits of the 16-week peanut trial

The trial was registered before its first participant started, with brain insulin sensitivity named up front as a primary outcome alongside brain blood flow. The published summary reports one cluster from a whole-brain analysis but doesn’t explain how it handled the many comparisons a search like that involves. The money came from The Peanut Institute Foundation (“Funding was provided by The Peanut Institute Foundation,” the release says), and the researchers say the foundation had no involvement in design, conduct, analysis, interpretation or writing. I’ve seen nothing to contradict that. The mixed-nut study was funded by the International Nut and Dried Fruit Council. A university lab doing careful MRI work on a food-industry grant is ordinary nutrition science. A single cluster with a weaker insulin response became “a surprising brain benefit” on your phone because the industry wrote the press release, and that release is the version ScienceDaily ran.

I’m not adding 60 grams of peanuts a day to protect my brain’s insulin signaling. If a second trial, bigger than 31 people and paid for by someone other than the peanut business, finds that blunted response tracking with better memory, I’ll buy the jar.

Sources

  1. Kerkhof et al., Food & Function, 2026
  2. Food & Function abstract on PubMed (PMID 42841520)
  3. ClinicalTrials.gov: NCT05724654, longer-term effects of peanut consumption on brain function
  4. Kerkhof et al., Clinical Nutrition, 2025
  5. Nijssen et al., American Journal of Clinical Nutrition, 2024: mixed nuts and brain insulin sensitivity
  6. Akintola et al., Aging, 2017: intranasal insulin and cerebral blood flow
  7. PsyPost: design, outcomes and limits of the 16-week peanut trial
  8. ScienceDaily: “Scientists discover a surprising brain benefit of eating peanuts every day” (The Peanut Institute release)
  9. EurekAlert: The Peanut Institute release on the 2025 Clinical Nutrition results